US › Healthcare

Curis Inc (CRIS)

US · Healthcare · Biotechnology

$4.72-8.35%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Revenue YoY
-100.0%
Net profit
$-24.2M
Profit YoY
-127.9%
EPS
$-25.00
EPS estimate
$-5.80

EPS came in at -25.00 against a street estimate of -5.80 — a miss of 331.0%.

Key statistics

Market cap
$9.8M
Forward P/E
0.0
P/B
0.78
Book value
$6.36
EPS (TTM)
$-11.76
52-week high
$39.00
52-week low
$3.60
50-day MA
$7.29
200-day MA
$16.58
Beta
3.07

Analyst view

Analysts rate Curis Inc a strong buy (5 buy, 0 hold, 0 sell out of 5) with an average price target of $42.67.

Shareholding

Insiders
8.03%
Institutions
40.50%

Largest institutional holders

FundStake
Bleichroeder LP9.75%
Stonepine Capital Management Llc9.56%
Nantahala Capital Management, LLC5.13%
Sphera Funds Management Ltd.5.12%
Cable Car Capital LLC3.42%
Dauntless Investment Group, LLC1.69%
Vanguard Capital Management, LLC0.96%
Renaissance Technologies Corp0.94%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Curis Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.